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It has been recognized for over a century that the eye is
endowed with remarkable properties that permit the
long-term survival of foreign tumor and tissue grafts
that are normally rejected at extraocular sites.This ocu-
lar immune privilege was originally attributed to a pu-
tative sequestration of antigens in the eye as a result of
the conspicuous absence of intraocular lymphatic drai-
nage channels. In the last 30 years, a sizeable body of
information indicates that ocular immune privilege is
a product of multiple anatomical, physiological, and
immunoregulatory processes. Ocular tissues and £uids
express a wide variety of anti-in£ammatory and im-
munosuppressive molecules, including CD95L (FasL),
transforming growth factor-b, macrophage migration
inhibitory factor, a-melanocyte^stimulating hormone,
calcitonin gene^related peptide, somatostatin, and com-
plement regulatory proteins. Moreover, antigens enter-
ing the anterior chamber of the eye evoke a unique
form of immune deviation that culminates in the anti-
gen-speci¢c suppression of TH1 immune responses.
Finally, the intraocular milieu contains both cell
membrane and soluble factors that inhibit both the
adaptive and innate immune systems. The hair follicle
is also recognized for its immune privilege. Like the
anterior chamber of the eye, it produces anti-in£amma-
tory and immunosuppressive cytokines, such as trans-
forming growth factor-b and adrenocorticotrophic
hormone. The cells of the hair follicle display limited
expression of class Ia MHC molecules and, like cells that
line the anterior chamber of the eye, are protected
against CD8þ cytotoxic T lymphocyte attack. Gaining
a better understanding of the immune privilege of the
hair follicle may provide insights into the regulation
and pathogenesis of immune-mediated diseases of
the skin. Keywords: Eye/hair follicle/immune privilege. JID
Symposium Proceedings 8:168 ^172, 2003
I
t has been recognized for over a century that the anterior
chamber (AC) of the eye is a highly permissive site for the
transplantation of tumor and tissue grafts that would other-
wise be rejected following transplantation to nonocular
sites (Barker, 1977; Head and Billingham, 1985). In the nine-
teenth century, van Dooremaal (1873) and Zahn (1884) noted the
prolonged survival of human tumor cells and fetal cartilage xe-
nografts in the AC of rabbits’eyes. In the 1940s, Greene and Lund
(1944) transplanted human tumor cells into the AC of the rabbit
eye as a bioassay for determining the malignancy of biopsy speci-
mens. Ten years later, the ground-breaking studies of Medawar
¢rmly established the role of the immune system in organ graft
rejection and set the stage for understanding the unique immu-
nological properties of the eye (Medawar, 1945; Medawar, 1948;
Billingham et al, 1954). The prolonged survival of foreign tissue
grafts in the AC of the eye and brain led Medawar to conclude
that the AC was endowed with a remarkable immune privilege
(Medawar, 1948). The absence of patent lymph vessels draining
the interior of the eye led Medawar to conclude that the eye’s
immune privilege is a consequence of antigen sequestrationa
phenomenon that contemporary immunologists would come to
know as ‘‘immunological ignorance.’’
Dynamic Regulatory Processes that Contribute to Immune
Privilege It was not for another two decades that this
paradigm was re-examined when Kaplan and Streilein injected
allogeneic lymphoid cells into the AC of rat eyes and noted that
alloantigens introduced into the eye not only were perceived by
the systemic immune apparatus but in fact elicited an aberrant
immune response that was characterized by an antigen-speci¢c
downregulation of cell-mediated alloimmunity and a con-
comitant activation of humoral antibody responses (Kaplan et al,
1975; Kaplan and Streilein, 1977). This deviant form of systemic
alloimmunity was termed ‘‘lymphocyte-induced immune
deviation’’ (Kaplan and Streilein, 1977). Subsequent investigations
by Niederkorn and Streilein demonstrated that the immune
deviation induced by AC injection of alloantigens was not a
property of the lymphoid cells injected into the AC, but was a
stereotypic immune response that was elicited when virtually
any antigen was delivered into the AC (Niederkorn et al, 1981;
Streilein et al, 1997). Accordingly, they coined the term ‘‘anterior
chamber^associated immune deviation’’ (ACAID) to stress the
dynamic nature of the systemic immune response to antigens
introduced into the AC and the crucial role of the eye in
deviating the immune response down an unconventional
pathway (Streilein and Niederkorn, 1981). The ACAID pheno-
type is characterized by a profound, antigen-speci¢c down-
regulation of TH1 immune responses, such as delayed-type
hypersensitivity (DTH) and a concomitant stimulation of non-
complement-¢xing IgG1 antibody and cytotoxic T lymphocyte
(CTL) responses (Niederkorn, 2002). As a result of the original
studies of Kaplan and Streilein (Kaplan et al, 1975; Kaplan and
Streilein, 1977), ACAID has been demonstrated with a panoply
of antigens, including viruses, haptenated cells, soluble proteins,
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tumor antigens, and histocompatibility antigens (Niederkorn,
2002).
Immunoregulatory Factors in the Intraocular Milieu In
addition to ACAID, multiple factors contribute to the immune
privilege in the AC. The aqueous humor (AH) that ¢lls the
AC and bathes the endothelium of the cornea possesses
remarkable immunosuppressive and anti-in£ammatory pro-
perties. Constituents of the AH suppress mitogen- and antigen-
driven lymphocyte proliferation in vitro (Benezra and Sachs,
1974; Kaiser et al, 1989). The AH also suppresses the expre-
ssion of DTH responses in situ. That is, previously activated TH1
cells that produce DTH lesions in the skin fail to produce
in£ammatory lesions when introduced into the AC (Niederkorn
et al, 1990; Cousins et al, 1991). At least four di¡erent AH-borne
factors suppress DTH responses in the eye: (i) TGF-b, (ii) a-mela-
nocyte^stimulating hormone, (iii) vasoactive intestinal peptide,
and (iv) calcitonin gene^related peptide (Taylor, 1999). These
factors exert other immunological e¡ects that in£uence immune
privilege in the AC. TGF-b2, at concentrations found in the AH,
alters the behavior of antigen-presenting cells (APC) and
downregulates their production of the TH1-inducing cytokine
IL-12 while stimulating their synthesis of the TH2 cytokine IL-
10 (D’Orazio and Niederkorn, 1998). Moreover, TGF-b2 suppres-
ses the activation of Tcells and induces APC to present antigen in
a manner that culminates in the generation of ACAID rather than
in conventional TH1 immune responses (Niederkorn, 2002).
TGF-b2 also downregulates the expression of class I major
histocompatibility complex (MHC) antigens (Ma and Nieder-
korn, 1995) and inhibits the cytolytic machinery of natural killer
(NK) cells (Rook et al, 1986).
Immune privilege in the AC of the eye is also extended to
elements of the innate immune system. The single corneal
endothelial cell layer that lines the AC expresses little or no
detectable class I or II MHC determinants (Niederkorn, 2002).
The absence of conventional class Ia MHC antigens renders
corneal endothelial cells highly vulnerable to NK cell^mediated
lysis (Apte and Niederkorn, 1996). Although NK cells readily
kill class I negative corneal endothelial cells in vitro, there is no
evidence of NK cell^mediated injury to the corneal
endothelium in vivo, even in conditions in which NK cells tra⁄c
through the eye. The absence of NK cell^mediated injury to
the corneal endothelium in vivo is presumably the result of the
inhibitory e¡ects of the AH. At least two cytokines are present
in the AH that independently suppress NK cell^mediated
cytolysis: macrophage migration inhibitory factor (MIF) and
TGF-b2 (Rook et al, 1986; Apte and Niederkorn, 1996; Apte et al,
1998).Thus, the absence of MHC class I determinants protects the
corneal endothelium from injury in£icted by class I^restricted,
CD8þCTL, but concomitantly renders this cell layer poten-
tially vulnerable to attack by NK cells that are programmed
to kill any cell failing to express MHC class I antigens (Ciccone
et al, 1994; Ljunggren et al, 1991). The bu¡ering e¡ects of the NK
inhibitory factors in the AH counteract the vulnerability created
by the absence of MHC class I antigens.
The innate immune apparatus also includes the complement
system, which can in£ict considerable injury to innocent
bystander cells by recruiting and activating in£ammatory cells
such as neutrophils. Complement-related injury is minimized in
the eye, however, by complement regulatory proteins that are
found in the AH and vitreous (Lass et al, 1990; Goslings et al,
1998; Sohn et al, 2000). Corneal cells express complement
regulatory proteins on their cell membranes, thereby providing
additional protection against intraocular activation of the
complement cascade (Bora et al, 1993; Lass et al, 1990). One
theory holds that continuous low levels of complement
activation are regular events in the eye, but injury to innocent
bystander ocular cells is minimized by complement regulatory
proteins in the AH and on the corneal cell membranes. This
proposition is supported by studies in rats, which show that
in vivo administration of antibodies that block complement
regulatory proteins results in severe uveitis (Sohn et al, 2000).
Cell Membrane^Bound Molecules That Promote Immune
Privilege in the Eye The cells that line the interior of the
eye also contribute to ocular immune privilege. The apopto-
sis-inducing cell membrane molecule, FasL (CD95L), is widely
expressed on ocular cells and is e¡ective in deleting
in£ammatory cells that enter the eye in response to various
insults such as viral infections (Gri⁄th et al, 1995). FasL on
corneal cells augments the immune privilege of corneal
allografts. That is, corneal allografts failing to express functional
FasL are twice as likely to undergo immune rejection as are
corneal grafts that display normal FasL (Stuart et al, 1997;
Yamagami et al, 1997).
In addition to FasL, cells lining the AC are decorated with
complement regulatory proteins (Lass et al, 1990; Bora et al,
1993; Sohn et al, 2000). The expression of complement decay^
accelerating factor on the corneal epithelium appears to pro-
tect this cell layer of corneal allografts from cytolysis by
complement-¢xing alloantibody. Corneal epithelial cells from
C57BL/6 mice are totally resistant to lysis by complement-¢xing
anti-C57BL/6 alloantiserum that is highly lytic for C57BL/6
lymphocytes (Hargrave et al, 2000; Hegde et al, 2002). By
contrast, corneal endothelial cells are highly susceptible to lysis
by complement-¢xing alloantibody in vitro, but are not adversely
a¡ected in vivo because passive transfer of alloantibody does not
culminate in corneal allograft rejection (Hegde et al, 2002). The
endothelium of the corneal allograft is continuously bathed in
the AH, which undoubtedly has a bu¡ering e¡ect due to the
complement regulatory proteins that are constitutively present
in the AH.
Classical class Ia MHC molecules are either feebly expressed or
absent on many cells within the eye (Fujikawa et al, 1982; Bakker
and Kijlstra, 1985; LeBouteiller, 1994; Niederkorn et al, 1999;
Treseler et al, 1984). According to the ‘‘missing self ’’ hypothesis,
the presence of classical class Ia MHC molecules is crucial
for transmitting inhibitory signals to NK cells, which are
programmed to kill MHC class I negative cells (Ljunggren et al,
1991). Thus, ocular cells failing to express adequate quantities of
MHC class I molecules are potential targets for cytolysis by NK
cells. However, murine ocular cells failing to express classical class
Ia MHC molecules display signi¢cant expression of Qa-2
molecules (Niederkorn et al, 1999). Qa-2 is a family of
nonclassical, class Ib molecules that are closely associated with
tolerance and are believed to exert anti-in£ammatory e¡ects.
Moreover, nonclassical class Ib MHC molecules are capable of
sending ‘‘o¡ signals’’ to NK cells. The latter property has
important implications in protecting ocular cells that fail to
express classical class Ia MHC molecules and are not bathed
byAH.
WHAT IS THE RAISON D’E’TRE OF OCULAR
IMMUNE PRIVILEGE ANDWHAT HAPPENSWHEN
PRIVILEGE IS LOST?
The eye is an extension of the brain, both embryologically and
anatomically, and possesses the remarkable neurological complex-
ity of the central nervous system. Like other elements of the
central nervous system, many ocular cells cannot regenerate if
injured by trauma or in£ammation. Dampening potentially in-
jurious in£ammatory responses in the eye has obvious bene¢t
for protecting such ocular tissues from irreparable damage. Ac-
cordingly, it is not surprising that multiple mechanisms contri-
bute to ocular immune privilege (Table 1; Fig 1). Like any
homeostatic mechanism, however, immune privilege has its
limitations.
When ocular immune privilege breaks down, the conse-
quences can be blinding. It is noteworthy that the leading causes
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of infectious blindness are immune mediated. The nematode
Onchocerca volvulus a¡ects over 17 million people and accounts for
over 250,000 cases of corneal blindness (Pearlman, 1997). Between
6 and 9 million people are blind because of trachoma, a chlamy-
dial infection of the cornea (Taylor and Bell, 1991). In the United
States, herpes simplex virus produces keratitis in 20,000 people
each year and is the leading cause of infectious blindness in North
America (Liesegang et al, 1989). The blindness produced by each
of these infectious diseases is immune mediated (Pearlman, 1997;
Streilein et al, 1997; Niederkorn, 2002). In each case, an overexu-
berant TH1- or TH2-mediated in£ammatory response to the
ocular pathogen results in extensive collateral damage to innocent
bystander cells in the eye. In ridding the eye of the pathogen, the
immune system unwittingly in£icts irreparable damage to ocular
tissues that are incapable of regeneration. The teleological argu-
ment might be made that ocular immune privilege yields to
pathogens that are potentially life threatening and releases the im-
mune system to protect the host, even at the risk of blindness.
The blinding e¡ect of autoimmune diseases of the eye is
further evidence of the importance of ocular immune privilege.
Autoimmune responses to retinal and uveal antigens produce in-
£ammation of the uveal tract and are signi¢cant causes of visual
loss in humans and animals. Results from animal studies have
shown that antigens present in the retina and uveal tract are po-
tentially immunogenic if combined with potent adjuvants and
introduced outside of the eye. The resulting in£ammatory eye
disease, called experimental autoimmune uveitis (EAU), has been
a model for studying the pathogenesis and immunobiology of a
variety of naturally occurring in£ammatory eye diseases. The re-
latively rare incidence of uveitis in the human population, how-
ever, and the exceptional manipulations that are needed for
inducing EAU in animals support the notion that ocular immune
privilege is an e¡ective mechanism for protecting the eye against
immune-mediated injury provoked by ocular autoantigens.
Immune Privilege of the Hair Follicle Billingham and
Silvers were the ¢rst to suggest that the epithelial hair bulb was
endowed with immune privilege (Billingham and Silvers, 1971).
Their conclusion was based on observations with skin allografts
exchanged between pigmented donors and albino recipients. The
skin grafts from black guinea pig donors became depigmented
and were presumed to have been rejected; however, the
subsequent emergence of black hair shafts in the graft bed
indicated that at least some of the donor melanocytes had
escaped immune rejection and had survived in the hosts’ hair
bulbs. It was concluded that the hosts’ hair shafts had o¡ered the
donor melanocytes sanctuary from immunological attack. In the
30 years since the seminal observations of Silvers and Billingham,
the immune privilege of the hair follicle has garnered only
limited interest from the dermatological and immunological
research communities (Paus et al, 1999).
The immunological architecture of the hair follicle provides
clues for explaining its immune privilege. The growth stage of
the hair follicle, anagen, is characterized by a conspicuous
absence of class Ia MHC antigens in the proximal hair follicle
epithelium (Westgate et al, 1991; Christoph et al, 2000; Paus et al,
1999). Cells of the immune system are also sparsely distributed in
the hair follicle. The entire lower two-thirds of the anagen hair
follicle is devoid of antigen-presenting Langerhans cells (LC)
(Moresi and Horn, 1997; Paus et al, 1999). Only scant numbers of
NK cells, CD4þT cells, and CD8þT cells are found in the
lower portions of the proximal hair follicle and bulb (Christoph
et al, 2000).
A number of studies have demonstrated the e¡ect of hair cycle
on the immunobiology of the skin (Claesson and Hardt, 1970;
Ho¡man et al, 1996; Tokura et al, 1997). Contact hypersensitivity
(CHS) is inhibited when haptens are administered to skin in
which all of the hair follicles are synchronized in telogen
(Hofmann et al, 1998). The hyporesponsiveness to haptens has
been attributed to the local production of immunosuppressive
factors, such as TGF-b (Gruschwitz et al, 1990; Schmid et al, 1996)
and adrenocorticotrophic hormone (Slominski et al, 1993), that are
elaborated in anagen hair follicles.
Although there are some similarities in the mechanisms of
immune privilege of the hair follicle and eye, there are
noteworthy di¡erences. FasL is believed to contribute to the
immune privilege of the eye, but is absent from the hair follicle
Figure1. Immune privilege in the eye involves multiple mechan-
isms and factors: a-MSH (a-melanocyte^stimulating hormone), ACAID
(anterior chamber^associated immune deviation), CGRP (calcitonin
gene^related protein), CRP (complement regulatory proteins), MIF
(macrophage migration inhibitory factor), TGF-b transforming growth
factor-b, vasoactive active intestinal peptide.
Table1. Factors that Support Immune Privilege in the Eye
E¡ect on Immune Privilege Factor Location















Deletion of in¢ltrating FasL Cornea, iris, retina,
in£ammatory cells ciliary body
Inhibition of NK cells MIF AH, lens, cornea
TGF-b2 AH
Qa-2? Cornea, iris, retina,
ciliary body
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(Christoph et al, 2000). ACAID plays a major role in sustaining
immune privilege in the eye; however, the possibility that an
ACAID-like phenomenon occurs in the hair follicle has not
been addressed to date. It is not known if NK cells and other
components of the innate immune apparatus are restrained in
the hair follicle as they are in the eye.
If the anagen hair bulb is an immune-privileged site, what is
the adaptive advantage of having an ‘‘immunological blind spot’’
in an organ that serves as a major barrier to a panoply of
environmental pathogens? It has been suggested that follicular
immune privilege might function to prevent potential auto-
antigens in the skin from provoking deleterious autoimmune
responses (Paus et al, 1999). One wonders if the putative location
of keratinocyte stem cells in the ‘‘bulge’’ area of the hair follicle
not only shields these crucial cells from environmental factors
but also protects them from immune-mediated injury. Although
there are many intriguing questions that beg to be addressed, the
original observation by Billingham and Silvers demonstrating
that the hair follicle provides sanctuary to allogeneic melano-
cytes is still as provocative today as it was three decades ago and
hints that immune privilege of the hair follicle has yet to reveal
all of its secrets (Billingham and Silvers, 1971).
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